R Jeremy Johnson

Title: R Jeremy Johnson: Innovator in Cytotoxic Ribonuclease Variants

Introduction

R Jeremy Johnson is a prominent inventor based in Middleton, WI (US). He has made significant contributions to the field of biochemistry, particularly in the development of cytotoxic ribonuclease variants. With a total of 5 patents to his name, Johnson's work has the potential to impact therapeutic approaches in medicine.

Latest Patents

Among his latest patents are innovations related to cytotoxic variants of human ribonuclease 1 (RNase 1). These variants have been identified through detailed analysis of the interaction between RNase 1 and the human ribonuclease inhibitor (hRI). The patents disclose the three-dimensional (3-D) atomic structure of the RNase 1-hRI complex, along with methods for designing and utilizing these RNase 1 variants. This research opens new avenues for therapeutic applications in treating various diseases.

Career Highlights

R Jeremy Johnson is associated with the Wisconsin Alumni Research Foundation, where he continues to advance his research. His work has garnered attention for its innovative approach to understanding ribonuclease interactions and their implications in medical science.

Collaborations

Johnson has collaborated with notable colleagues, including Ronald Thaddeus Raines and George N Phillips, Jr. These partnerships have further enriched his research and contributed to the development of his patented technologies.

Conclusion

R Jeremy Johnson's contributions to the field of biochemistry, particularly through his patents on cytotoxic ribonuclease variants, highlight his role as an influential inventor. His work not only advances scientific understanding but also holds promise for future medical applications.